Federal award
QUIDELORTHO SALES COMPANY, LLC
FA283522P0005
Contract
Obligated and Ceiling
- Obligated (net)
- $123,677.81
- Ceiling (potential value, not spending)
- $153,157.90
- Current value
- $153,157.90
- Gross positive obligations
- $153,157.90
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- QUIDELORTHO SALES COMPANY, LLC · ZFXRG96JMJ39
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- QUIDELORTHO SALES COMPANY, LLC · ZFXRG96JMJ39
- Awarding agency
- Department of War · sub-agency 5700 · office FA2835
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- FA283522P0005
- Award type code
- B
- Actions
- 7 · Dec 20, 2021 to Dec 29, 2025
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History7
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Dec 29, 2025 | FY2026 | P00006 | G | $30,631.58 | — |
| Dec 4, 2025 | FY2026 | P00005 | J | $0.00 | — |
| May 30, 2025 | FY2025 | P00004 | C | −$29,480.09 | — |
| Jan 6, 2025 | FY2025 | P00003 | G | $30,631.58 | — |
| Dec 19, 2023 | FY2024 | P00002 | G | $30,631.58 | — |
| Dec 30, 2022 | FY2023 | P00001 | G | $30,631.58 | — |
| Dec 20, 2021 | FY2022 | 0 | — | $30,631.58 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.